In 2023, HIV-AIDS female mortality in the US was recorded at 1.24 thousand deaths. The forecast data for 2024 to 2028 suggests a decreasing trend in mortality: 1.23, 1.22, 1.21, 1.20, and 1.19 thousand female deaths, respectively. Year-on-year decline is consistent, averaging a reduction of approximately 0.81% annually. The compound annual growth rate (CAGR) over the five-year period is -0.81%, indicating a gradual decrease in female mortality from HIV-AIDS.
Future trends to watch include advancements in medical treatments, accessibility to healthcare services, and public health policies. These factors could further influence the mortality rates positively, with a potential acceleration in the declining trend.
